149 related articles for article (PubMed ID: 9532471)
1. Systemic lupus erythematosus and the eye.
Nguyen QD; Foster CS
Int Ophthalmol Clin; 1998; 38(1):33-60. PubMed ID: 9532471
[No Abstract] [Full Text] [Related]
2. Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study.
Mok CC; Lau CS; Wong RW
Am J Med; 2003 Jul; 115(1):59-62. PubMed ID: 12867236
[No Abstract] [Full Text] [Related]
3. [Systemic lupus erythematosus with neurologic onset and secondary antiphospholipid syndrome. A Case Study].
Dima-Cozma C; Pandele GI; Rezuş E; Constantinescu A; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):254-8. PubMed ID: 16607781
[TBL] [Abstract][Full Text] [Related]
4. Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus.
Lavalle-Graef A; Villegas-Acosta L; Lavalle C
Arch Med Res; 2004; 35(5):421-7. PubMed ID: 15610913
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus. Diagnosis and treatment.
Pisetsky DS; Gilkeson G; St Clair EW
Med Clin North Am; 1997 Jan; 81(1):113-28. PubMed ID: 9012757
[TBL] [Abstract][Full Text] [Related]
6. [Initial manifestation by cerebral vasculitis in systemic lupus erythematosus].
Mrabet D; Meddeb N; Sahli H; Rammeh N; Sellami S
Tunis Med; 2008 Jun; 86(6):618-9. PubMed ID: 19216467
[No Abstract] [Full Text] [Related]
7. Ocular manifestations of systemic lupus erythematosus.
Davies JB; Rao PK
Curr Opin Ophthalmol; 2008 Nov; 19(6):512-8. PubMed ID: 18998618
[TBL] [Abstract][Full Text] [Related]
8. A serological switching from anti-dsDNA to anti-Sm antibodies coincided with severe clinical manifestations of systemic lupus erythematosus (hemophagocytosis, profundus and psychosis).
Ishii M; Muramoto Y; Kosaka H; Ohshima S; Mima T; Katada Y; Hirohata S; Saeki Y
Lupus; 2007; 16(1):67-9. PubMed ID: 17283590
[No Abstract] [Full Text] [Related]
9. [Systemic veupus erythematosus. Possibilities and limitations of treatment].
Kahn MF
Nouv Presse Med; 1972 Mar; 1(13):849-51. PubMed ID: 4537003
[No Abstract] [Full Text] [Related]
10. [The treatment of disseminated lupus erythematosus. So-called immunosuppressive drugs].
Clément F
Schweiz Med Wochenschr; 1970 Feb; 100(7):333-5. PubMed ID: 4189917
[No Abstract] [Full Text] [Related]
11. Ocular manifestations in systemic lupus erythematosus.
Silpa-archa S; Lee JJ; Foster CS
Br J Ophthalmol; 2016 Jan; 100(1):135-41. PubMed ID: 25904124
[TBL] [Abstract][Full Text] [Related]
12. Successful pregnancy and delivery in a case of systemic lupus erythematosus treated with immunoadsorption therapy and cyclosporin A.
Maeshima E; Yamada Y; Kodama N; Mune M; Yukawa S
Scand J Rheumatol; 1999; 28(1):54-7. PubMed ID: 10092166
[TBL] [Abstract][Full Text] [Related]
13. Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-α antibody-treated patients with inflammatory bowel disease.
Beigel F; Schnitzler F; Paul Laubender R; Pfennig S; Weidinger M; Göke B; Seiderer J; Ochsenkühn T; Brand S
Inflamm Bowel Dis; 2011 Jan; 17(1):91-8. PubMed ID: 20564536
[TBL] [Abstract][Full Text] [Related]
14. Splenic infarction in a pregnant woman with systemic lupus erythematosus.
Soy M; Sayin NC; Unlü E
Clin Rheumatol; 2005 Nov; 24(6):663-4. PubMed ID: 15714383
[TBL] [Abstract][Full Text] [Related]
15. Changes in anti-DNA antibody affinity during exacerbations of systemic lupus erythematosus.
Hale GM; Highton J; Kalmakoff J; Palmer DG
Scand J Rheumatol; 1986; 15(3):243-50. PubMed ID: 3492037
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of anti-native DNA antibodies in systemic lupus erythematosus by the Crithidia luciliae method].
Pigrau C; Martínez-Vázquez JM; Bacardi R; Pahissa A; Pastor M; Guardia J
Med Clin (Barc); 1984 Jul; 83(6):227-31. PubMed ID: 6332255
[No Abstract] [Full Text] [Related]
17. Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome.
Steiman AJ; Gladman DD; Ibañez D; Urowitz MB
J Rheumatol; 2010 Sep; 37(9):1822-7. PubMed ID: 20595281
[TBL] [Abstract][Full Text] [Related]
18. A spectrum of lupus erythematosus from verrucous to systemic, coexisting with two types of porphyria.
Bharati A; Kleyn E; Wong GA; Leonard N; King CM
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):1009-10. PubMed ID: 17659034
[No Abstract] [Full Text] [Related]
19. Ocular involvement in systemic lupus erythematosus.
Preble JM; Silpa-archa S; Foster CS
Curr Opin Ophthalmol; 2015 Nov; 26(6):540-5. PubMed ID: 26367085
[TBL] [Abstract][Full Text] [Related]
20. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
